156 related articles for article (PubMed ID: 319235)
1. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
Thijssen HH
J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
[TBL] [Abstract][Full Text] [Related]
3. P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
Seydel JK; Butte W
J Med Chem; 1977 Mar; 20(3):439-47. PubMed ID: 321779
[TBL] [Abstract][Full Text] [Related]
4. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
Thijssen HH
Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
[No Abstract] [Full Text] [Related]
5. The effect of mafenide on dihydropteroate synthase.
Eagon RG; McManus AT
J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
[TBL] [Abstract][Full Text] [Related]
6. Phosphanilic acid inhibits dihydropteroate synthase.
Eagon RG; McManus AT
Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
McCullough JL; Maren TH
Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
[TBL] [Abstract][Full Text] [Related]
9. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
Lever OW; Bell LN; McGuire HM; Ferone R
J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
Swedberg G; Castensson S; Sköld O
J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of 4-amino 4-deoxychorismate synthase from Escherichia coli.
Viswanathan VK; Green JM; Nichols BP
J Bacteriol; 1995 Oct; 177(20):5918-23. PubMed ID: 7592344
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
[TBL] [Abstract][Full Text] [Related]
13. PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity.
Saavedra JE; Srinivasan A; Buzard GS; Davies KM; Waterhouse DJ; Inami K; Wilde TC; Citro ML; Cuellar M; Deschamps JR; Parrish D; Shami PJ; Findlay VJ; Townsend DM; Tew KD; Singh S; Jia L; Ji X; Keefer LK
J Med Chem; 2006 Feb; 49(3):1157-64. PubMed ID: 16451080
[TBL] [Abstract][Full Text] [Related]
14. Relation between structure of sulphonamides and inhibition of H2-pteroate synthesis in Escherichia coli.
Thijssen HH
J Pharm Pharmacol; 1974 Apr; 26(4):228-34. PubMed ID: 4151377
[No Abstract] [Full Text] [Related]
15. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
[TBL] [Abstract][Full Text] [Related]
16. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
17. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
18. Sulfa drugs strike more than once.
Patel OG; Mberu EK; Nzila AM; Macreadie IG
Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
[No Abstract] [Full Text] [Related]
19. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
20. Determination of protease-cleaved p-aminobenzoic acid (PABA) in serum after oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA-peptide) in children.
Dockter G; Nacu I; Kohlberger E
Eur J Pediatr; 1981 Feb; 135(3):277-9. PubMed ID: 6971754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]